Evidence map›Paper›PMID 40400399›Full record

ArticleHLA2025

Association Between HLA-DRB1 Serotype and HLA-DQB1 Allele Mismatches and Acute Rejection in Kidney Transplantation.

Renato de Marco, Isau H Noronha, Luiza Zainotti Miguel Fahur Bottino, Tuila Bittencourt Mourão, Gisele Fabianne Rampim, João Campos, Alberto Cardoso Martins Lima, Lúcio Requião-Moura, Hélio Tedesco-Silva, José Medina Pestana and 1 more

Abstract read
In one paragraph

Article in HLA, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Renato de MarcoInstituto de Imunogenética (IGEN), Associação Fundo de Incentivo à Pesquisa (AFIP), São Paulo, São Paulo, Brazil.ORCID 0000-0002-8388-6403
Isau H NoronhaInstituto de Imunogenética (IGEN), Associação Fundo de Incentivo à Pesquisa (AFIP), São Paulo, São Paulo, Brazil.ORCID 0000-0002-3676-9749
Luiza Zainotti Miguel Fahur BottinoInstituto de Imunogenética (IGEN), Associação Fundo de Incentivo à Pesquisa (AFIP), São Paulo, São Paulo, Brazil.ORCID 0000-0003-0373-7019
Tuila Bittencourt MourãoInstituto de Imunogenética (IGEN), Associação Fundo de Incentivo à Pesquisa (AFIP), São Paulo, São Paulo, Brazil.
Gisele Fabianne RampimInstituto de Imunogenética (IGEN), Associação Fundo de Incentivo à Pesquisa (AFIP), São Paulo, São Paulo, Brazil.
João CamposInstituto de Imunogenética (IGEN), Associação Fundo de Incentivo à Pesquisa (AFIP), São Paulo, São Paulo, Brazil.ORCID 0000-0002-8590-8442
Alberto Cardoso Martins LimaInstituto de Imunogenética (IGEN), Associação Fundo de Incentivo à Pesquisa (AFIP), São Paulo, São Paulo, Brazil.ORCID 0000-0002-7248-7060
Lúcio Requião-MouraNephrology Division, Universidade Federal de São Paulo, São Paulo, São Paulo, Brazil.ORCID 0000-0001-8751-9048
Hélio Tedesco-SilvaNephrology Division, Universidade Federal de São Paulo, São Paulo, São Paulo, Brazil.ORCID 0000-0002-9896-323X
José Medina PestanaNephrology Division, Universidade Federal de São Paulo, São Paulo, São Paulo, Brazil.ORCID 0000-0002-0750-7360
Maria Gerbase-DeLimaInstituto de Imunogenética (IGEN), Associação Fundo de Incentivo à Pesquisa (AFIP), São Paulo, São Paulo, Brazil.ORCID 0000-0003-3616-4579

Funding

Associação Fundo de Incentivo à PesquisaCoordenação de Aperfeiçoamento de Pessoal de Nível Superior
6 · The paper itself

Abstract

The purpose of this single-center case-control study was to investigate the association between HLA serotype mismatch (MM), compared to other HLA MM modalities, and the occurrence of acute rejection (AR) within the first year after deceased donor kidney transplantation. The study included 198 transplants in 99 pairs of recipients of kidneys from the same donor, where one recipient experienced AR and the other survived the first year without AR. Donors and recipients were typed with NGS for 11 HLA loci at high resolution. HLA MM categories included allele groups, alleles, serotypes, amino acids, EMMA, eplet and PIRCHE-II. Additionally, we investigated Cytomegalovirus LIL peptide (CMV LIL) MM. Recipients with AR presented higher frequencies of pre-transplant HLA-ABDR DSA (20.2% vs. 6.1%, p = 0.005) and CMV LIL MM (24.2% vs. 10.1%, p = 0.01). Univariate and multivariate Cox proportional hazards regression for matched-pair analyses were used to test the association between HLA MM and AR. Univariate analyses indicated significant association with DRB1 ST, HLA-DQB1 AG, HLA-DQB1 AL, EMMA C, EMMA DQB1, Eplet ABC and Eplet DQ MM. Different models were tested in multivariate analyses, all including pre-transplant HLA-ABDR DSA and CMV LIL MM. The models were compared using the Akaike Information Criterion (AIC). The best estimate for AR prediction (AIC = 97.6) was the model that included pre-transplant HLA-ABDR DSA (HR = 11.97; p = 0.003), CMV LIL MM (HR = 367.2; p < 0.001), HLA-DRB1 serotype MM (9.65; p = 0.002) and HLA-DQB1 allele MM (HR = 3.54; p = 0.033). In conclusion, this original report demonstrates an association between the HLA-DRB1 serotype MM and AR, highlighting that serotypes are clinically relevant.

Indexed as

AllelesGraft RejectionHLA-DQ beta-ChainsHLA-DRB1 ChainsKidney TransplantationAdultCase-Control StudiesFemaleHistocompatibility TestingHumansMaleMiddle AgedSerogroupHLA-DQB1 antigenHLA-DQ beta-ChainsHLA-DRB1 Chainsacute rejectionamino acid mismatchesEMMAEpletHLA compatibilityHLA mismatchHLA serotypesmolecular mismatchesPIRCHE

Identifiers

PMID40400399
PMCPMC12096148

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.